MODULATION OF NERVE AND GLIAL FUNCTION BY ADENOSINE - ROLE IN THE DEVELOPMENT OF ISCHEMIC DAMAGE

Adenosine is released during brain ischemia and provides neuroprotection by actions on nerve and glial cells. Activation of the adenosine A(1) receptor enhances the K+ and Cl- conductance in neurons, leading to membrane hyperpolarization and postsynaptic reduction of neuronal Ca2+ influx through voltage- and NMDA receptor-dependent channels. In addition adenosine A(1) receptor activation decreases excitatory amino acid release, possibly via inhibition of N- and P-type Ca2+ channels. The A(1) and A(2) receptors, coupled to G(i)/G(o) and G(s) proteins respectively, often co-exist and interact with the phospholipase C-dependent activation of the protein kinase C and the adenylyl cyclase. Activation of the A(1) receptor may mimic metabotropic receptor stimulation in activating intracellular Ca2+ mobilization and PKC. A(2) receptor mediated cAMP formation is depressed by high intracellular Ca2+ but enhanced by PKC activation. By modulating these metabolic signaling events, adenosine may influence acute cell functions, gene transcription and sustained changes of nerve and glial cells relevant for the development of ischemic damage. The neuroprotective adenosine effect seems to be amplified by treatment with propentofylline, which enhances adenosine release, influences the balance between A(1) and A(2) receptor mediated actions, depresses the free radical formation in activated microglia and influences astrocyte reactions.